New bone graft material for neck surgery under safety review

NCT ID NCT07245940

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks back at medical records of 300 people who had neck spine fusion surgery using a special graft material called NMP®. The goal is to see how safe it is by checking for complications and whether patients needed another surgery within 90 days to 2 years. The researchers hope to learn if this human bone allograft is a safe option for treating degenerative spine conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Natural Matrix Protein (NMP) Fibers (human bone allograft)
What this could lead to
If successful, this could confirm that NMP® graft material is a safe option for cervical spine fusion, potentially reducing complications and reoperations.
What could go wrong
This is a retrospective chart review, not a controlled trial, so results may be influenced by missing data or patient selection. It only assesses safety, not effectiveness, and the follow-up is short (minimum 90 days).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alabama Back Institute

    Jasper, Alabama, 35501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.